COMMUNIQUÉS West-GlobeNewswire

Tempus Launches New Mobile App to Make Clinical and Genomic Data More Accessible to Physicians at the Point of Care
19/09/2018
CHICAGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, today announced the launch of its new [...]
Merit Medical to Present at Three Upcoming Conferences
19/09/2018
SOUTH JORDAN, Utah, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Ovid Therapeutics to Present at Two Investor Healthcare Conferences in October 2018
19/09/2018
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Nexstim Plc to Present Depression Led Strategy at Investor Conference Sijoittaja 2018 in Helsinki
19/09/2018
Press release, Helsinki, 19 th September 2018 at 4:00 PM EEST Nexstim Plc to Present Depression Led Strategy at Investor Conference Sijoittaja 2018 in Helsinki Nexstim Plc to host a Conference Call / Webcast on Tuesday [...]
BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
19/09/2018
Pompano Beach, FL, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]
Aduro Biotech Announces the Departure of Natalie R. Sacks, M.D.
19/09/2018
BERKELEY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Natalie R. Sacks, M.D. has resigned from her position as the company’s chief medical officer effective October [...]
Genmab to Host Capital Markets Day
19/09/2018
Media Release Review of Genmab’s progress and operations Event will take place at Genmab’s R&D Center in Utrecht, the Netherlands Event will be webcast live with an archived version available Copenhagen, Denmark; [...]
Bravo’s Wellness Strategy Team Expands
19/09/2018
CLEVELAND, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Bravo announces the addition of Deanna Wolfe to its growing wellness strategy team. Wolfe joins Bravo from Limeade, where she worked directly with top customers using data [...]
Eyenovia to Participate in Panel Presentation at OSN New York 2018
19/09/2018
CEO Sean Ianchulev to join industry panel discussion on “Medical and Surgical Management of Corneal Conditions and Complications” NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a [...]
Zosano Pharma Completes Manufacture of M207 Registration Batches
19/09/2018
FREMONT, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company focused on providing rapid systemic administration of [...]
Achaogen Announces Multiple Plazomicin Presentations at IDWeek 2018
19/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterials addressing multi-drug [...]
Spero Therapeutics to Present at the Cantor Global Healthcare Conference in October
19/09/2018
CAMBRIDGE, Mass., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments [...]
BioSig Technologies to Commence Trading on the Nasdaq
19/09/2018
Trading to Begin on the Nasdaq Capital Market on September 21, 2018 Santa Monica, CA, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( OTCQB:BSGM, OTCQB:BSGMD ), a medical device company developing a [...]
Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease
19/09/2018
REDWOOD CITY, Calif., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]
Cynata’s Cymerus™ MSCs Ameliorate Cytokine Release Syndrome in Preclinical Study
19/09/2018
• Cymerus MSCs demonstrate substantial protection against CRS symptoms, a serious adverse reaction caused by cancer immunotherapies such as CAR-T MELBOURNE, Australia, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Australian stem [...]
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
19/09/2018
The Agreement Will Support the Development of a Potential New Treatment Option for Multiple Myeloma AUSTIN, Texas, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq:MTEM) today announced an agreement [...]
Scilex Announces Pricing and Availability of ZTlido™ for the Commercial Launch of its First Product in October of 2018
19/09/2018
SAN DIEGO, Sept. 19, 2018 (GLOBE NEWSWIRE) -- Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (Sorrento), today announced that the Wholesale Acquisition Cost (WAC) for [...]
AIT Therapeutics Presented Nitric Oxide Data at the European Respiratory Society International Congress 2018
19/09/2018
GARDEN CITY, N.Y. and REHOVOT, Israel, Sept. 19, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
The American Health Council Welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians
19/09/2018
NEW YORK, Sept. 19, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Hartmuth B. Bittner, MD, Ph.D., FACS to its Board of Physicians for his outstanding contributions to the medical field. Dr. Bittner [...]

Pages